Previous 10 | Next 10 |
Ardelyx Provides Corporate Update Following Type A Meeting with FDA - Despite Type A Meeting, Ardelyx continues to await clarity from FDA on path forward for approval of tenapanor for hyperphosphatemia - Company reduces staff by 65% PR Newswire FREMONT, Calif. ...
Radnor, Pennsylvania--(Newsfile Corp. - September 4, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds Ardelyx Inc. (NASDAQ: ARDX) ("Ardelyx") investors that a securities fraud class action lawsuit has been filed against Ardelyx on behalf of those who purchased or acquired...
Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial Publication highlights clinically meaningful reduction in mean serum phosphorus from 7.7 mg/dL to 5.1 mg/dL at end of 26-week treatment period in the efficacy analysis set. PR Newswire FREMONT, Cal...
With another week upon us, investors are looking for the best penny stocks to buy. And, in 2021, there are quite a lot of catalysts that are impacting the market. The biggest impact right now is, of course, the pandemic. With Covid cases rising in the U.S. and abroad, many investors have tu...
Boston, Massachusetts--(Newsfile Corp. - August 16, 2021) - Block & Leviton announces that a class action lawsuit has been filed against Ardelyx Inc. (NASDAQ: ARDX) and certain of its officers for securities law violations. Investors who purchased shares between August 6, 2020 and Ju...
China Finance Online (NASDAQ:JRJC) -43% after receiving Nasdaq delisting notice and announces private placement of ordinary shares and warrants Sesen Bio (NASDAQ:SESN) -36% after FDA declines to approve Sesen Bio's Vicineum bladder cancer treatment Standard Lithium (N...
RADNOR, PA / ACCESSWIRE / August 14, 2021 / The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against Ardelyx Inc. (NASDAQ:ARDX) ("Ardelyx") on behalf of those who purchased or acquired Ardelyx securities be...
Ardelyx Reports Second Quarter 2021 Financial Results PR Newswire FREMONT, Calif. and WALTHAM, Mass. , Aug. 13, 2021 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the discovery, development, and commercialization of...
BOSTON, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Ardelyx, Inc. (NASDAQ: ARDX) for potential securities law violations. Investors who have lost money should contact the firm to learn more about how they might recover those losses. For more details, please vi...
Ardelyx (ARDX -0.9%) has implemented a restructuring plan after the FDA turned down the approval of the company’s kidney disease therapy tenapanor in July. The plan expected to be complete in Q3 2021 will lead to a nearly 33% decline in the company’s workforce and a ~$17M d...
News, Short Squeeze, Breakout and More Instantly...
Why The Stock Market Is Down Today Why is the stock market down today? The final week of June and the second quarter has been jam-packed with economic data and inflation-related events. Fed Chair Jerome Powell recently said that the global economy has entered a “new world”...
Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners PR Newswire HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA ® in the United States in exchange for future hyperphosphatemia royalty payments from ...
Ardelyx Announces FDA Advisory Committee Meeting to Review XPHOZAH® NDA Tentatively Scheduled for November 16, 2022 PR Newswire WALTHAM, Mass. , June 21, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a missio...